Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Forschungszentrum für Immuntherapie (FZI)

Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Ochs, Jasmin; Schweineberg, Pia; Klein, Matthias et al.

Besides B cells, CD19 is expressed on a fraction of T cells and monocytes, which are concomitantly depleted by anti-CD19 inebilizumab

MULTIPLE SCLEROSIS JOURNAL. Bd. 31. H. 3. 2025 S. 1149-1150


Frenking, Jan H.; Zhou, Xiang; Rejeski, Kai et al.

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

BLOOD ADVANCES. Bd. 9. H. 16. 2025 S. 4151-4166


Worel, Nina; Mooyaart, Jarl E.; Hoogenboom, Jorinde D. et al.

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

BONE MARROW TRANSPLANTATION. Bd. 60. H. 8. 2025 S. 1184-1186


Leypoldt, Lisa B.; Guo, Linlin; Besemer, Britta et al.

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial

CARDIO-ONCOLOGY. Bd. 11. H. 1. 2025



Denk, Alexander; Fante, Matthias Alexander; Heidenreich, Silke et al.

Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland

TRANSPLANTATION AND CELLULAR THERAPY. Bd. 31. H. 7. 2025 S. 450e1-450e10


Mandel, Sebastian; Hanke, Thomas; Prendiville, Niall et al.

Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor

JOURNAL OF MEDICINAL CHEMISTRY. Bd. 68. H. 14. 2025 S. 15026-15049


Hebbar Subramanyam, Sudheendra; Turyne Hriczko, Judit; Schulz, Saskia et al.

CREB regulates Foxp3<SUP>+</SUP>ST-2<SUP>+</SUP> T<sub>REGS</sub> with enhanced IL-10 production

FRONTIERS IN IMMUNOLOGY. Bd. 16. 2025


Rafei, Hind; Basar, Rafet; Acharya, Sunil et al.

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

NATURE. Bd. 643. H. 8073. 2025


Ahmed, Azaz; Springfeld, Christoph; Halama, Niels

De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer

SIGNAL TRANSDUCTION AND TARGETED THERAPY. Bd. 10. H. 1. 2025